Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,675 | 777 | 99.4% |
| Education | $87.21 | 6 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,838 | 114 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,199 | 74 | $0 (2022) |
| ABBVIE INC. | $1,121 | 79 | $0 (2024) |
| Lilly USA, LLC | $1,018 | 63 | $0 (2024) |
| Amgen Inc. | $916.29 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $807.56 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $685.30 | 31 | $0 (2024) |
| Allergan, Inc. | $625.98 | 32 | $0 (2020) |
| Avanir Pharmaceuticals, Inc. | $586.91 | 30 | $0 (2022) |
| Arbor Pharmaceuticals, Inc. | $552.60 | 49 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,630 | 84 | Amgen Inc. ($335.22) |
| 2023 | $1,568 | 81 | Novo Nordisk Inc ($316.90) |
| 2022 | $1,319 | 82 | Novo Nordisk Inc ($255.68) |
| 2021 | $2,085 | 122 | AbbVie Inc. ($296.02) |
| 2020 | $1,655 | 92 | Allergan, Inc. ($273.52) |
| 2019 | $1,405 | 88 | ARBOR PHARMACEUTICALS, INC. ($215.51) |
| 2018 | $1,991 | 113 | SANOFI-AVENTIS U.S. LLC ($288.58) |
| 2017 | $2,108 | 121 | Avanir Pharmaceuticals, Inc. ($372.17) |
All Payment Transactions
783 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Seqirus USA Inc | Flucelvax (Biological) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: Vaccines | ||||||
| 11/26/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: DERMATOLOGY | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: PAIN | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.01 | General |
| Category: Inflammation | ||||||
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Diabetes | ||||||
| 08/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $27.72 | General |
| 08/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $35.92 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $2.79 | General |
| Category: Inflammation | ||||||
| 07/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 293 | 447 | $63,969 | $47,927 |
| 2022 | 13 | 408 | 571 | $82,920 | $60,496 |
| 2021 | 13 | 420 | 666 | $124,436 | $67,780 |
| 2020 | 13 | 472 | 792 | $160,382 | $78,491 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 221 | $24,826 | $17,703 | 71.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 61 | 61 | $9,794 | $9,510 | 97.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 73 | $11,504 | $8,005 | 69.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 42 | $9,297 | $6,679 | 71.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $7,044 | $4,851 | 68.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 17 | 23 | $1,505 | $1,180 | 78.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 202 | $22,913 | $15,981 | 69.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 88 | $13,955 | $10,001 | 71.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 44 | 44 | $11,880 | $7,823 | 65.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 40 | 40 | $6,427 | $6,351 | 98.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 27 | $5,892 | $4,609 | 78.2% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 23 | 28 | $5,398 | $4,153 | 76.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 31 | $5,118 | $2,964 | 57.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 11 | 35 | $3,747 | $2,964 | 79.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $2,518 | $1,961 | 77.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 24 | 29 | $2,237 | $1,443 | 64.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 12 | 12 | $1,735 | $1,162 | 67.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 12 | 12 | $783.12 | $770.02 | 98.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $317.88 | $312.58 | 98.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 65 | 124 | $38,326 | $11,880 | 31.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 75 | 154 | $14,890 | $10,233 | 68.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 35 | 35 | $8,709 | $6,598 | 75.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 62 | $8,597 | $5,997 | 69.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 40 | 40 | $5,807 | $5,807 | 100.0% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 13 | 40 | $6,411 | $5,048 | 78.7% |
About Dr. Suneetha Maddineni, M.D
Dr. Suneetha Maddineni, M.D is a Internal Medicine healthcare provider based in Mountain View, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2012. The National Provider Identifier (NPI) number assigned to this provider is 1962774679.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Suneetha Maddineni, M.D has received a total of $13,762 in payments from pharmaceutical and medical device companies, with $1,630 received in 2024. These payments were reported across 783 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($13,675).
As a Medicare-enrolled provider, Maddineni has provided services to 1,593 Medicare beneficiaries, totaling 2,476 services with total Medicare billing of $254,694. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Mountain View, CA
- Active Since 01/27/2012
- Last Updated 06/30/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962774679
Products in Payments
- XARELTO (Drug) $922.35
- VRAYLAR (Drug) $851.60
- Ozempic (Drug) $849.49
- NUEDEXTA (Drug) $545.60
- Repatha (Biological) $500.15
- JARDIANCE (Drug) $485.98
- Edarbi (Drug) $435.79
- FARXIGA (Drug) $409.86
- TRULICITY (Drug) $378.19
- Livalo (Drug) $371.34
- Victoza (Drug) $325.36
- UBRELVY (Drug) $323.33
- QULIPTA (Drug) $317.75
- NURTEC ODT (Drug) $317.47
- TRELEGY ELLIPTA (Drug) $316.96
- JANUVIA (Drug) $316.81
- Rybelsus (Drug) $289.98
- INVOKANA (Drug) $270.27
- Vascepa (Drug) $269.18
- TOUJEO (Drug) $232.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mountain View
Mr. Kenneth Peters, Md, MD
Internal Medicine — Payments: $111,214
Stephanie Wong, Md, MD
Internal Medicine — Payments: $23,168
Mr. Lawrence Epstein, Md, MD
Internal Medicine — Payments: $15,464
Sanjeev Tummala, Md, MD
Internal Medicine — Payments: $15,128
Joseph Chao, M.d, M.D
Internal Medicine — Payments: $14,752
Edward Huang, Md, Mph, MD, MPH
Internal Medicine — Payments: $9,951